Search

Your search keyword '"Technau K"' showing total 104 results

Search Constraints

Start Over You searched for: Author "Technau K" Remove constraint Author: "Technau K"
104 results on '"Technau K"'

Search Results

1. Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

2. Evaluating the performance of the GeneXpert HIV‑1 qualitative assay as a consecutive test for a new early infant diagnosis algorithm in South Africa

3. The next generation: Pregnancy in adolescents and women living with perinatally acquired HIV in South Africa

6. Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity : An Observational Study

8. COVID-19 in pregnancy in South Africa: Tracking the epidemic and defining the natural history

10. Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation

14. Improving the coverage and accuracy of syphilis testing: The development of a novel rapid, point-of-care test for confirmatory testing of active syphilis infection and its early evaluation in China and South Africa

17. Global temporal changes in the proportion of children with advanced disease at the start of combination antiretroviral therapy in an era of changing criteria for treatment initiation

19. Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study

20. Field Performance and Diagnostic Accuracy of a Low-Cost Instrument-Free Point-of-Care CD4 Test (Visitect CD4) Performed by Different Health Worker Cadres among Pregnant Women

21. Pediatric Cancer Burden and Treatment Resources within the Pediatric IeDEA Consortium

22. Variability of growth in children starting antiretroviral treatment in southern Africa

23. Implementation of Tuberculosis Intensive Case Finding, Isoniazid Preventive Therapy, and Infection Control ('Three I's') and HIV-Tuberculosis Service Integration in Lower Income Countries

24. Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe

25. Optimal timing of antiretroviral treatment initiation in HIV-positive children and adolescents: a multiregional analysis from Southern Africa, West Africa and Europe

26. A biregional survey and review of first-line treatment failure and second-line paediatric antiretroviral access and use in Asia and southern Africa

29. Necrobiosis lipoidica

35. Reducing CD4 monitoring in children on antiretroviral therapy with virologic suppression

36. Outcomes of Infants Starting Antiretroviral Therapy in Southern Africa, 2004-2012

37. What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies

38. Growth and mortality outcomes for different antiretroviral therapy initiation criteria in children ages 1-5 years: A causal modeling analysis

39. Failing the vulnerable: Three new consent norms that will undermine health research with children.

41. Adolescent retention in HIV care within differentiated service-delivery models in sub-Saharan Africa.

42. Evaluating the performance of the GeneXpert HIV-1 qualitative assay as a consecutive test for a new early infant diagnosis algorithm in South Africa.

43. What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies.

44. Field Performance and Diagnostic Accuracy of a Low-Cost Instrument-Free Point-of-Care CD4 Test (Visitect CD4) Performed by Different Health Worker Cadres among Pregnant Women.

45. Lamivudine monotherapy as a holding regimen for HIV-positive children.

46. Insights into Adherence among a Cohort of Adolescents Aged 12-20 Years in South Africa: Reported Barriers to Antiretroviral Treatment.

47. Young age at start of antiretroviral therapy and negative HIV antibody results in HIV-infected children when suppressed.

48. Temporal trends in the characteristics of children at antiretroviral therapy initiation in southern Africa: the IeDEA-SA Collaboration.

49. When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa.

50. Paradoxical Mycobacterium tuberculosis meningitis immune reconstitution inflammatory syndrome in an HIV-infected child.

Catalog

Books, media, physical & digital resources